Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for targeted cancer therapies. Its chiral amine structure enables selective interactions with biological targets, enhancing drug efficacy and reducing off-target effects. Commonly employed in the preparation of active pharmaceutical ingredients (APIs) requiring high enantiomeric purity. Also utilized in medicinal chemistry research for structure-activity relationship (SAR) studies involving nitrogen-containing heterocyclic compounds.